Changing the world of diabetes: GLP-1 in T2DM

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1607, 2007-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations

By Jespersen Maria J Knop Filip K Christensen Mikkel

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 17-29

Informa Healthcare

Access to resources Recommend Favorite

GLP-1 agonists: a new approach for type 2 diabetes

Inpharma, Vol. 1, Iss. 1407, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Continuous GLP-1 (7-36) amide effective in type 2 diabetes

Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

GLP-1 7-36 amide: potential in type 2 diabetes

Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Insulin aspart: Type 2 diabetes mellitus following administration via SC infusion pump in a patient with T1DM: case report

Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite